GL Synthesis

GLSynthesis is a long-established, privately-held chemistry services provider operating at the intersection of custom synthesis and early-stage drug discovery. The company leverages its expertise in organic chemistry to offer research-scale synthesis, process R&D, and manufacturing (with production facilities in China) to a global client base. Beyond its core service business, GLSynthesis has developed the Fluorosome® technique, a proprietary drug delivery platform that represents a potential product-based growth avenue. Its dual model combines stable service revenue with the upside of an in-house technology platform.

Fluorosome® Technique, a proprietary drug delivery platform aimed at improving the properties of therapeutic compounds.

GLSynthesis competes in a fragmented market with numerous small to mid-sized chemistry CROs and large, full-service CROs like Charles River Laboratories, Labcorp, and WuXi AppTec. Its differentiation is based on specific chemistry expertise, long-term client relationships, and its proprietary Fluorosome® platform, which few pure-service CROs possess.